This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GlaxoSmithKline Initiates A Multi-city Conversation Focused On Improving The Health Of US Communities

The United States spends more per capita on health care than any other nation, but there are large disparities in health outcomes in relation to race, community of residence, and individual and community socioeconomic factors. Some American communities are falling behind the best performing nations in life expectancy, while rates of obesity, asthma and other diseases continue to rise. 1

The Philadelphia area, home to approximately 5,000 GSK employees, is a natural choice for the first stop in this multi-city program due to its significant health challenges. Two-thirds of adults and 40 percent of children in Philadelphia are overweight or obese. One quarter of adults in the city smoke, and smoking-related complications are a leading cause of death. 2 ,3   The number of residents with chronic health conditions — such as high blood pressure and diabetes — increased over the past decade and remains significantly higher than the national average. 4  

These problems persist in spite of the vibrant life sciences industry, leading academic and medical institutions and community-based non-profit and city efforts that have demonstrated real success. 

Additional information about "A Conversation on Community Health," hosted by The Atlantic - The Philadelphia town hall will be available via live stream from 3 – 5 pm ET on Monday, September 24 at http://events.theatlantic.com

Over the course of the three city program, The Atlantic will be exploring the many facets of community health through an ongoing special report available at http://theatlantic.com/special-report/health-nation.

Join the conversation on Twitter @GSKUS or @Atlantic_Live, #HealthyCommunity.

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information go to us.gsk.com, follow us on twitter.com/GSKUS or visit our blog ( www.morethanmedicine.us.gsk.com/blog/).

1 Kulkarni et al. Population Health Metrics 2011, 9:16 http://www.pophealthmetrics.com/content/9/1/16

2  City of Philadelphia, Mayor Nutter's Soda Summit Address, June 7, 2012. http://cityofphiladelphia.wordpress.com/2012/06/07/mayor-nutters-soda-summit-address

3 Philadelphia Department of Public Health, Tobacco Control Program: 16 July 15, 2009.

4 Pew Research Initiative. Philadelphia 2011 The State of the City. The Pew Charitable Trusts 2011: 51-58. http://www.pewtrusts.org/uploadedFiles/wwwpewtrustsorg/Reports/Philadelphia_Research_Initiative/Philadelphia-City-Data-Population-Demographics.pdf. Accessed  Aug. 30, 2012.

Cautionary statement regarding forward-looking statements Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2011.

SOURCE GlaxoSmithKline

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,351.38 +293.03 1.82%
S&P 500 1,948.86 +35.01 1.83%
NASDAQ 4,749.9790 +113.8740 2.46%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs